Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo

H. Bártíková, I. Vokřál, L. Skálová, J. Lamka, B. Szotáková

. 2010 ; 40 (9) : 593-601.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Dicrocoeliosis, a parasitic infection caused by Dicrocoelium dendriticum (lancet fluke), is often treated by the anthelmintic drug albendazole (ABZ). In the lancet fluke, ABZ metabolism via enzymatic sulphoxidation was found, but no information about ABZ oxidases has been available. The aim of our project was to find out which enzyme of the lancet fluke is responsible for ABZ sulphoxidation, as well as to assay the activities of oxidation enzymes. We also studied whether ex vivo 24-h exposures of flukes to ABZ or its sulphoxide (ABZ.SO) would alter ABZ sulphoxidation rate and the activities of tested enzymes. In subcellular fractions from flukes, marked activities of peroxidase (Px), glutathione Px (GPx), catalase (CAT), superoxide dismutase, and thioredoxin glutathione reductase were found. Using specific inhibitors, the participation of flavine monooxygenases in ABZ-oxidation was found. The ex vivo exposition of flukes to ABZ or ABZ.SO did not change the rate of ABZ sulphoxidation in vitro, but the ex vivo exposure of flukes to anthelmintics increased Px, CAT, and GPx activity. The modulation of these enzyme activities after ABZ or ABZ.SO exposition may be characteristic of the parasite’s protective mechanism against oxidative stress caused by drug treatment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027407
003      
CZ-PrNML
005      
20160229103328.0
007      
ta
008      
120816s2010 enk f 000 0#eng||
009      
AR
024    7_
$a 10.3109/00498254.2010.497565 $2 doi
035    __
$a (PubMed)20560773
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bártíková, H $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic $7 xx0335122
245    10
$a In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo / $c H. Bártíková, I. Vokřál, L. Skálová, J. Lamka, B. Szotáková
520    9_
$a Dicrocoeliosis, a parasitic infection caused by Dicrocoelium dendriticum (lancet fluke), is often treated by the anthelmintic drug albendazole (ABZ). In the lancet fluke, ABZ metabolism via enzymatic sulphoxidation was found, but no information about ABZ oxidases has been available. The aim of our project was to find out which enzyme of the lancet fluke is responsible for ABZ sulphoxidation, as well as to assay the activities of oxidation enzymes. We also studied whether ex vivo 24-h exposures of flukes to ABZ or its sulphoxide (ABZ.SO) would alter ABZ sulphoxidation rate and the activities of tested enzymes. In subcellular fractions from flukes, marked activities of peroxidase (Px), glutathione Px (GPx), catalase (CAT), superoxide dismutase, and thioredoxin glutathione reductase were found. Using specific inhibitors, the participation of flavine monooxygenases in ABZ-oxidation was found. The ex vivo exposition of flukes to ABZ or ABZ.SO did not change the rate of ABZ sulphoxidation in vitro, but the ex vivo exposure of flukes to anthelmintics increased Px, CAT, and GPx activity. The modulation of these enzyme activities after ABZ or ABZ.SO exposition may be characteristic of the parasite’s protective mechanism against oxidative stress caused by drug treatment.
650    _2
$a albendazol $x analogy a deriváty $x metabolismus $x farmakokinetika $x farmakologie $7 D015766
650    _2
$a zvířata $7 D000818
650    _2
$a biotransformace $x účinky léků $7 D001711
650    _2
$a Dicrocoelium $x účinky léků $x enzymologie $x metabolismus $7 D004013
650    _2
$a inhibitory enzymů $x farmakologie $7 D004791
650    _2
$a glutathionperoxidasa $x metabolismus $7 D005979
650    _2
$a oxidace-redukce $x účinky léků $7 D010084
650    _2
$a ovce $x parazitologie $7 D012756
650    _2
$a subcelulární frakce $x účinky léků $x enzymologie $7 D013347
650    _2
$a xenobiotika $x metabolismus $7 D015262
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vokřál, Ivan $7 _AN067830 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
700    1_
$a Skálová, Lenka, $d 1965- $7 mzk2004230464 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
700    1_
$a Lamka, Jiří, $d 1953- $7 nlk19990073481 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
700    1_
$a Szotáková, Barbora $7 jx20070426012 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
773    0_
$w MED00004746 $t Xenobiotica; the fate of foreign compounds in biological systems $x 1366-5928 $g Roč. 40, č. 9 (2010), s. 593-601
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20560773 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160229103045 $b ABA008
999    __
$a ok $b bmc $g 949449 $s 784753
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 40 $c 9 $d 593-601 $i 1366-5928 $m Xenobiotica $n Xenobiotica $x MED00004746
LZP    __
$b NLK112 $a Pubmed-20120816/11/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...